{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:52:46Z","timestamp":1793303566867,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Jilin Province","award":["NO. YDZJ202201ZYTS116"],"award-info":[{"award-number":["NO. YDZJ202201ZYTS116"]}]},{"name":"Jilin Province Department of Finance Project","award":["NO. JLSWSRCZX2020-0011"],"award-info":[{"award-number":["NO. JLSWSRCZX2020-0011"]}],"id":[{"id":"https:\/\/ror.org\/05rjrj969","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Jilin Province Health and Technology Innovation Project","award":["NO.2018J045"],"award-info":[{"award-number":["NO.2018J045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11198-1","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:31:17Z","timestamp":1752154277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Causal relationship between immune mediators and parkinson\u2019s disease: A Mendelian randomization analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Ruqing","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"11198_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye, H., Robak, L. A., Yu, M., Cykowski, M. & Shulman, J. M. Genetics and pathogenesis of parkinson\u2019s syndrome. Annu. Rev. Pathol. 18, 95\u2013121 (2023).","journal-title":"Annu. Rev. Pathol."},{"key":"11198_CR2","doi-asserted-by":"publisher","first-page":"1119315","DOI":"10.3389\/fimmu.2023.1119315","volume":"14","author":"M Yi","year":"2023","unstructured":"Yi, M. et al. Quantitative and causal analysis for inflammatory genes and the risk of parkinson\u2019s disease. Front. Immunol. 14, 1119315 (2023).","journal-title":"Front. Immunol."},{"issue":"1","key":"11198_CR3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1186\/s12888-023-05081-4","volume":"23","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study. BMC Psychiatry. 23 (1), 590 (2023).","journal-title":"BMC Psychiatry"},{"issue":"8","key":"11198_CR4","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer, P. L., Itagaki, S., Boyes, B. E. & McGeer, E. G. Reactive microglia are positive for HLA-DR in the substantia Nigra of parkinson\u2019s and alzheimer\u2019s disease brains. Neurology 38 (8), 1285\u20131291 (1988).","journal-title":"Neurology"},{"issue":"1","key":"11198_CR5","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1038\/s41467-023-39060-w","volume":"14","author":"AM Schonhoff","year":"2023","unstructured":"Schonhoff, A. M. et al. Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease. Nat. Commun. 14 (1), 3754 (2023).","journal-title":"Nat. Commun."},{"issue":"4","key":"11198_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/ana.26034","volume":"89","author":"MP Jensen","year":"2021","unstructured":"Jensen, M. P. et al. Lower lymphocyte count is associated with increased risk of parkinson\u2019s disease. Ann. Neurol. 89 (4), 803\u2013812 (2021).","journal-title":"Ann. Neurol."},{"issue":"5","key":"11198_CR7","doi-asserted-by":"publisher","first-page":"e1036","DOI":"10.1212\/NXI.0000000000001036","volume":"8","author":"Z Yan","year":"2021","unstructured":"Yan, Z. et al. Dysregulation of the adaptive immune system in patients with Early-Stage Parkinson disease. Neurol. Neuroimmunol. Neuroinflamm 8(5), e1036 (2021).https:\/\/doi.org\/10.1212\/NXI.0000000000001036","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"11198_CR8","doi-asserted-by":"publisher","first-page":"617370","DOI":"10.3389\/fnagi.2021.617370","volume":"13","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Shang, evidence for peripheral immune activation in parkinson\u2019s disease. Front. Aging Neurosci. 13, 617370 (2021).","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"11198_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12264-017-0163-9","volume":"33","author":"L Cen","year":"2017","unstructured":"Cen, L. et al. Peripheral lymphocyte subsets as a marker of parkinson\u2019s disease in a Chinese population. Neurosci. Bull. 33 (5), 493\u2013500 (2017).","journal-title":"Neurosci. Bull."},{"issue":"1","key":"11198_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic, N. et al. Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4\u2009+\u2009Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients. J. Neuroinflammation. 15 (1), 205 (2018).","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"11198_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","volume":"16","author":"DD \u00c1lvarez-Luqu\u00edn","year":"2019","unstructured":"\u00c1lvarez-Luqu\u00edn, D. D. et al. Regulatory impairment in untreated parkinson\u2019s disease is not restricted to tregs: other regulatory populations are also involved. J. Neuroinflammation. 16 (1), 212 (2019).","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"11198_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12974-022-02481-3","volume":"19","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Parkinson\u2019s disease peripheral immune biomarker profile: a multicentre, cross-sectional and longitudinal study. J. Neuroinflammation. 19 (1), 116 (2022).","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"11198_CR13","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/mds.28015","volume":"35","author":"RS Wijeyekoon","year":"2020","unstructured":"Wijeyekoon, R. S., Moore, S. F., Farrell, K., Breen, D. P. & Barker, R. A. Williams-Gray, cerebrospinal fluid cytokines and Neurodegeneration-Associated proteins in parkinson\u2019s disease. Mov. Disord. 35 (6), 1062\u20131066 (2020).","journal-title":"Mov. Disord"},{"issue":"7","key":"11198_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.26563","volume":"31","author":"CH Williams-Gray","year":"2016","unstructured":"Williams-Gray, C. H. et al. Serum immune markers and disease progression in an incident parkinson\u2019s disease cohort (ICICLE-PD). Mov. Disord. 31 (7), 995\u20131003 (2016).","journal-title":"Mov. Disord"},{"issue":"1","key":"11198_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"CH Lin","year":"2019","unstructured":"Lin, C. H. et al. Altered gut microbiota and inflammatory cytokine responses in patients with parkinson\u2019s disease. J. Neuroinflammation. 16 (1), 129 (2019).","journal-title":"J. Neuroinflammation"},{"key":"11198_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-genom-083117-021731","volume":"19","author":"S Burgess","year":"2018","unstructured":"Burgess, S., Foley, C. N. & Zuber, V. Inferring causal relationships between risk factors and outcomes from Genome-Wide association study data. Annu. Rev. Genomics Hum. Genet. 19, 303\u2013327 (2018).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"1","key":"11198_CR17","first-page":"1","volume":"29","author":"S Nattel","year":"2013","unstructured":"Nattel, S. Canadian journal of cardiology January 2013: genetics and more. Can. J. Cardiol. 29 (1), 1\u20132 (2013).","journal-title":"Can. J. Cardiol."},{"issue":"4","key":"11198_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","volume":"4","author":"J Zheng","year":"2017","unstructured":"Zheng, J. et al. Recent developments in Mendelian randomization studies. Curr. Epidemiol. Rep. 4 (4), 330\u2013345 (2017).","journal-title":"Curr. Epidemiol. Rep."},{"issue":"1","key":"11198_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1001\/jamaneurol.2019.3419","volume":"77","author":"S Bandres-Ciga","year":"2020","unstructured":"Bandres-Ciga, S., Noyce, A. J. & Traynor, B. J. Mendelian Randomization-A journey from obscurity to center stage with a few potholes along the way. JAMA Neurol. 77 (1), 7\u20138 (2020).","journal-title":"JAMA Neurol."},{"issue":"1","key":"11198_CR20","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41598-024-53287-7","volume":"14","author":"J Song","year":"2024","unstructured":"Song, J. et al. Exploring the causal relationship between B lymphocytes and parkinson\u2019s disease: a bidirectional, two-sample Mendelian randomization study. Sci. Rep. 14 (1), 2783 (2024).","journal-title":"Sci. Rep."},{"issue":"3","key":"11198_CR21","doi-asserted-by":"publisher","first-page":"e0299026","DOI":"10.1371\/journal.pone.0299026","volume":"19","author":"J Tian","year":"2024","unstructured":"Tian, J., Zuo, C., Shi, J., Ma, D. & Shi, C. Peripheral immune cell traits and parkinson\u2019s disease: A Mendelian randomization study. PLoS One. 19 (3), e0299026 (2024).","journal-title":"PLoS One"},{"issue":"10","key":"11198_CR22","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9, V. et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat. Genet. 52 (10), 1036\u20131045 (2020).","journal-title":"Nat. Genet."},{"issue":"9","key":"11198_CR23","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao, J. H. et al. Genetics of Circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat. Immunol. 24 (9), 1540\u20131551 (2023).","journal-title":"Nat. Immunol."},{"issue":"12","key":"11198_CR24","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18 (12), 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"issue":"6","key":"11198_CR25","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/jcsm.12788","volume":"12","author":"WQ Lv","year":"2021","unstructured":"Lv, W. Q. et al. Human gut Microbiome impacts skeletal muscle mass via gut microbial synthesis of the short-chain fatty acid butyrate among healthy menopausal women. J. Cachexia Sarcopenia Muscle. 12 (6), 1860\u20131870 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"11198_CR26","doi-asserted-by":"publisher","first-page":"1370276","DOI":"10.3389\/fimmu.2024.1370276","volume":"15","author":"J Long","year":"2024","unstructured":"Long, J., Dang, H., Su, W., Moneruzzaman, M. & Zhang, H. Interactions between Circulating inflammatory factors and autism spectrum disorder: a bidirectional Mendelian randomization study in European population. Front. Immunol. 15, 1370276 (2024).","journal-title":"Front. Immunol."},{"key":"11198_CR27","doi-asserted-by":"publisher","first-page":"1187906","DOI":"10.3389\/fimmu.2023.1187906","volume":"14","author":"Y Cao","year":"2023","unstructured":"Cao, Y., Lu, H., Xu, W. & Zhong, M. Gut microbiota and sj\u00f6gren\u2019s syndrome: a two-sample Mendelian randomization study. Front. Immunol. 14, 1187906 (2023).","journal-title":"Front. Immunol."},{"issue":"7","key":"11198_CR28","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37 (7), 658\u2013665 (2013).","journal-title":"Genet. Epidemiol."},{"issue":"2","key":"11198_CR29","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect Estimation and bias detection through Egger regression. Int. J. Epidemiol. 44 (2), 512\u2013525 (2015).","journal-title":"Int. J. Epidemiol."},{"issue":"5","key":"11198_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal Pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50 (5), 693\u2013698 (2018).","journal-title":"Nat. Genet."},{"issue":"10","key":"11198_CR31","doi-asserted-by":"publisher","first-page":"17459","DOI":"10.1002\/jcp.28367","volume":"234","author":"R Rouas","year":"2019","unstructured":"Rouas, R. et al. Human CD8(+) CD25 (+) CD127 (low) regulatory T cells: MicroRNA signature and impact on TGF-\u03b2 and IL-10 expression. J. Cell. Physiol. 234 (10), 17459\u201317472 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"11198_CR32","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1182\/blood.V97.10.2923","volume":"97","author":"J Baker","year":"2001","unstructured":"Baker, J., Verneris, M. R., Ito, M., Shizuru, J. A. & Negrin, R. S. Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. Blood 97 (10), 2923\u20132931 (2001).","journal-title":"Blood"},{"issue":"1","key":"11198_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12974-022-02685-7","volume":"19","author":"M Badr","year":"2022","unstructured":"Badr, M. et al. Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-\u03b1-synuclein parkinson\u2019s disease mice. J. Neuroinflammation. 19 (1), 319 (2022).","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"11198_CR34","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1038\/s41467-022-34526-9","volume":"13","author":"S Yazdani","year":"2022","unstructured":"Yazdani, S. et al. T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nat. Commun. 13 (1), 6733 (2022).","journal-title":"Nat. Commun."},{"issue":"5","key":"11198_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-015-1402-7","volume":"129","author":"A Waisman","year":"2015","unstructured":"Waisman, A., Hauptmann, J. & Regen, T. The role of IL-17 in CNS diseases. Acta Neuropathol. 129 (5), 625\u2013637 (2015).","journal-title":"Acta Neuropathol."},{"key":"11198_CR36","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","volume":"81","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of parkinson\u2019s disease. Brain Behav. Immun. 81, 630\u2013645 (2019).","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"11198_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3233\/JPD-191699","volume":"9","author":"HF Green","year":"2019","unstructured":"Green, H. F., Khosousi, S. & Svenningsson, P. Plasma IL-6 and IL-17A correlate with severity of motor and Non-Motor symptoms in parkinson\u2019s disease. J. Parkinsons Dis. 9 (4), 705\u2013709 (2019).","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"11198_CR38","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1007\/s12035-017-0404-y","volume":"55","author":"NP Rocha","year":"2018","unstructured":"Rocha, N. P. et al. Reduced activated T lymphocytes (CD4\u2009+\u2009CD25+) and plasma levels of cytokines in parkinson\u2019s disease. Mol. Neurobiol. 55 (2), 1488\u20131497 (2018).","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"11198_CR39","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00210-022-02357-6","volume":"396","author":"AS Gautam","year":"2023","unstructured":"Gautam, A. S., Pulivarthi, C. B. & Singh, R. K. Proinflammatory IL-17 levels in serum\/cerebrospinal fluid of patients with neurodegenerative diseases: a meta-analysis study. Naunyn Schmiedebergs Arch. Pharmacol. 396 (3), 577\u2013588 (2023).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"11198_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12974-022-02382-5","volume":"19","author":"N Liu","year":"2022","unstructured":"Liu, N. et al. TRPV4 contributes to ER stress and inflammation: implications for parkinson\u2019s disease. J. Neuroinflammation. 19 (1), 26 (2022).","journal-title":"J. Neuroinflammation"},{"key":"11198_CR41","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3389\/fimmu.2018.00763","volume":"9","author":"K Nakanishi","year":"2018","unstructured":"Nakanishi, K. Unique action of Interleukin-18 on T cells and other immune cells. Front. Immunol. 9, 763 (2018).","journal-title":"Front. Immunol."},{"issue":"3","key":"11198_CR42","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/mds.26488","volume":"31","author":"P Zhang","year":"2016","unstructured":"Zhang, P. et al. Cdk5-Dependent activation of neuronal inflammasomes in parkinson\u2019s disease. Mov. Disord. 31 (3), 366\u2013376 (2016).","journal-title":"Mov. Disord"},{"key":"11198_CR43","doi-asserted-by":"publisher","first-page":"578222","DOI":"10.1016\/j.jneuroim.2023.578222","volume":"385","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Plasma TNF-\u03b1 and phosphorylated \u03b1-syn are associated with fatigue in patients with parkinson\u2019s disease. J. Neuroimmunol. 385, 578222 (2023).","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"11198_CR44","doi-asserted-by":"publisher","first-page":"e1125","DOI":"10.1212\/NXI.0000000000001125","volume":"9","author":"R Li","year":"2022","unstructured":"Li, R. et al. A. Bar-Or, abnormal B-Cell and Tfh-Cell profiles in patients with Parkinson disease: A Cross-sectional study. Neurol. Neuroimmunol. Neuroinflamm 9(2), e1125 (2022).https:\/\/doi.org\/10.1212\/NXI.0000000000001125","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"11198_CR45","doi-asserted-by":"publisher","first-page":"105890","DOI":"10.1016\/j.parkreldis.2023.105890","volume":"116","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Abnormal immune function of B lymphocyte in peripheral blood of parkinson\u2019s disease. Parkinsonism Relat. Disord. 116, 105890 (2023).","journal-title":"Parkinsonism Relat. Disord"},{"issue":"2","key":"11198_CR46","doi-asserted-by":"publisher","first-page":"fcad060","DOI":"10.1093\/braincomms\/fcad060","volume":"5","author":"KM Scott","year":"2023","unstructured":"Scott, K. M. et al. B lymphocyte responses in parkinson\u2019s disease and their possible significance in disease progression. Brain Commun. 5 (2), fcad060 (2023).","journal-title":"Brain Commun."},{"key":"11198_CR47","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3389\/fimmu.2015.00632","volume":"6","author":"P Boss\u00f9","year":"2015","unstructured":"Boss\u00f9, P., Spalletta, G., Caltagirone, C. & Ciaramella, A. Myeloid dendritic cells are potential players in human neurodegenerative diseases. Front. Immunol. 6, 632 (2015).","journal-title":"Front. Immunol."},{"issue":"9","key":"11198_CR48","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/jclinpath-2020-206927","volume":"74","author":"MA Al Barashdi","year":"2021","unstructured":"Al Barashdi, M. A., Ali, A., McMullin, M. F. & Mills, K. Protein tyrosine phosphatase receptor type C (PTPRC or CD45). J. Clin. Pathol. 74 (9), 548\u2013552 (2021).","journal-title":"J. Clin. Pathol."},{"key":"11198_CR49","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.12659\/MSM.904240","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang, L. et al. Increased levels of Pro-Inflammatory and Anti-Inflammatory cellular responses in parkinson\u2019s disease patients: search for a disease Indicator. Med. Sci. Monit. 23, 2972\u20132978 (2017).","journal-title":"Med. Sci. Monit."},{"key":"11198_CR50","doi-asserted-by":"publisher","first-page":"914645","DOI":"10.3389\/fgene.2022.914645","volume":"13","author":"L Chen","year":"2022","unstructured":"Chen, L., Wang, Y., Huang, J., Hu, B. & Huang, W. Identification of Immune-Related hub genes in parkinson\u2019s disease. Front. Genet. 13, 914645 (2022).","journal-title":"Front. Genet."},{"key":"11198_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neulet.2017.03.045","volume":"648","author":"S Chen","year":"2017","unstructured":"Chen, S. et al. Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed parkinson\u2019s disease patients. Neurosci. Lett. 648, 21\u201325 (2017).","journal-title":"Neurosci. Lett."},{"issue":"10","key":"11198_CR52","doi-asserted-by":"publisher","first-page":"e2020858118","DOI":"10.1073\/pnas.2020858118","volume":"118","author":"K Farmen","year":"2021","unstructured":"Farmen, K., Nissen, SK., Stokholm, MG., Romero-Ramos, M., et al. , monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder. Proc. Natl. Acad. Sci. U S A 118(10), e2020858118 (2021).https:\/\/doi.org\/10.1073\/pnas.2020858118","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"19","key":"11198_CR53","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.3390\/ijms21197081","volume":"21","author":"C Szeto","year":"2020","unstructured":"Szeto, C. et al. Impact of HLA-DR antigen binding cleft rigidity on T cell recognition. Int. J. Mol. Sci. 21(19),  7081 (2020).https:\/\/doi.org\/10.3390\/ijms21197081","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"11198_CR54","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12974-021-02296-8","volume":"18","author":"D Bhatia","year":"2021","unstructured":"Bhatia, D. et al. T-cell dysregulation is associated with disease severity in parkinson\u2019s disease. J. Neuroinflammation. 18 (1), 250 (2021).","journal-title":"J. Neuroinflammation"},{"issue":"41","key":"11198_CR55","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1523\/JNEUROSCI.2344-04.2004","volume":"24","author":"O Cooper","year":"2004","unstructured":"Cooper, O. & Isacson, O. Intrastriatal transforming growth factor alpha delivery to a model of parkinson\u2019s disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons. J. Neurosci. 24 (41), 8924\u20138931 (2004).","journal-title":"J. Neurosci."},{"issue":"19","key":"11198_CR56","doi-asserted-by":"publisher","first-page":"14915","DOI":"10.3390\/ijms241914915","volume":"24","author":"DH Hepp","year":"2023","unstructured":"Hepp, D. H. et al. Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson\u2019s Disease. Int. J. Mol. Sci. 24(19), 14915   (2023).https:\/\/doi.org\/10.3390\/ijms241914915","journal-title":"Int. J. Mol. Sci."},{"key":"11198_CR57","doi-asserted-by":"publisher","first-page":"102499","DOI":"10.1016\/j.jaut.2020.102499","volume":"112","author":"HY Wong","year":"2020","unstructured":"Wong, H. Y. & Schwarz, H. CD137 \/ CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases. J. Autoimmun. 112, 102499 (2020).","journal-title":"J. Autoimmun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11198-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11198-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11198-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:38:30Z","timestamp":1757219910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11198-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11198"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11198-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The data was based on published studies or databases and no additional ethical approval from an institutional review board was required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"24884"}}